PMC:7473478 / 28362-28517 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T328","span":{"begin":27,"end":37},"obj":"Body_part"},{"id":"T329","span":{"begin":32,"end":37},"obj":"Body_part"},{"id":"T330","span":{"begin":108,"end":113},"obj":"Body_part"}],"attributes":[{"id":"A328","pred":"fma_id","subj":"T328","obj":"http://purl.org/sig/ont/fma/fma63368"},{"id":"A329","pred":"fma_id","subj":"T329","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A330","pred":"fma_id","subj":"T330","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T134","span":{"begin":51,"end":59},"obj":"Disease"}],"attributes":[{"id":"A134","pred":"mondo_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T360","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0001013"},{"id":"T361","span":{"begin":27,"end":37},"obj":"http://purl.obolibrary.org/obo/CL_0000034"},{"id":"T362","span":{"begin":108,"end":113},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T148","span":{"begin":122,"end":124},"obj":"Chemical"}],"attributes":[{"id":"A148","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}

{"project":"LitCovid-PubTator","denotations":[{"id":"965","span":{"begin":51,"end":59},"obj":"Disease"}],"attributes":[{"id":"A965","pred":"tao:has_database_id","subj":"965","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}

{"project":"LitCovid-sentences","denotations":[{"id":"T245","span":{"begin":0,"end":155},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Autologous adMSCs 200 3 doses of 200 million cells through IV every 3 days Phase 2 USA 49"}